Int. J. Mol. Sci., 2023 · DOI: 10.3390/ijms241311122 · Published: July 5, 2023
This study checks if it's possible to use several methods to assess pain in people who have recently suffered a spinal cord injury (SCI). These methods include clinical workup, sensory tests, psychological evaluations, and blood tests. The goal is to understand how pain changes over time in these patients and to find possible markers in the blood that could help predict who will develop long-term pain. The research found that while using all these methods is doable, it's difficult to recruit enough patients and that some adjustments to the testing procedures are necessary.
The five patients who underwent the entire protocol provide key insights into the therapeutic prospects that arise from such a comprehensive approach. This knowledge can guide the development of personalized, integrative care models for SCI-related pain, and potentially improve patient outcomes.
The identified trajectories may suggest changes in pain pathways in the early stage of SCI, highlighting the potential for early intervention strategies.
Promising molecules that may serve as future therapeutic targets or diagnostic tools were identified. Notably, IL-10, CCL3, MCP1, IL-6, CRP, calprotectin, cystatin-C, OPN, and ICAM-1 exhibited significant alterations.